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Ebola virus (Zaire subtype) is associated with high mortality disease outbreaks that commonly involve human to human
transmission. Surviving patients can show evidence of prolonged virus persistence. The potential for Ebola virus to generate
defective interfering (DI) particles and establish persistent infections in tissue culture was investigated. It was found that
serial undiluted virus passages quickly resulted in production of an evolving population of virus minireplicons possessing
both deletion and copyback type DI genome rearrangements. The tenth undiluted virus passage resulted in the establishment
of virus persistently infected cell lines. Following one or two crises, these cells were stably maintained for several months
with continuous shedding of infectious virus. An analysis of the estimated genome lengths of a selected set of the Ebola virus
minireplicons and standard filoviruses revealed no obvious genome length rule, such as “the rule of six” found for the
phylogenetically related Paramyxovirinae subfamily viruses. Minimal promoters for Ebola virus replication were found to be
contained within 156 and 177 nucleotide regions of the genomic and antigenomic RNA 39 termini, respectively, based on the
length of authentic termini retained in the naturally occurring minireplicons analyzed. In addition, using UV-irradiated
preparations of virus released from persistently infected cells, it was demonstrated that Ebola virus DI particles could
potentially be used as natural minireplicons to assay standard virus support functions.
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Viruses of the Filoviridae family include some of the
ost virulent infectious agents of human and nonhuman
rimates. They induce acute, rapidly progressing, fre-
uently fatal diseases typically characterized by hemor-
hages, shock, and multiorgan involvement (Bwaka et al.,
999). Primary targets appear to be endothelial and mac-
ophage cells, infection of which likely plays an important
ole in disease development (Feldmann et al., 1996). The
iloviruses are enveloped, nonsegmented, negative-
tranded RNA viruses with a characteristic filamentous,
leiomorphic shape when observed by electron micros-
opy. Two serologically (Feldmann et al., 1994) and ge-
etically (Sanchez et al., 1993, 1996) distinct filovirus
roups, designated Marburg and Ebola, exist in uniden-
ified primary reservoirs probably located in forest areas
f tropical Africa (Sanchez et al., 1996; Swanepoel et al.,
996). Phylogenetic analysis of all the currently charac-
erized Ebola viruses, including the most recent isolates
rom Gabon (Georges-Courbot et al., 1997; Volchkov et
l., 1997), reveals four distinct Ebola virus species: Zaire
including Gabon strains), Sudan, Reston, and Cote
’Ivoire.
Defective interfering (DI) particles have been observed
n viruses representing nearly all RNA virus families
1 To whom correspondence and reprint requests should be ad-
mressed. Fax: (404) 639-1118. E-mail: stn1@cdc.gov.
042-6822/99
114Perrault, 1981; Holland et al., 1982). They are infectious
nits containing truncated genomes and therefore re-
uire the presence of a full-length nondefective helper
irus (called “standard” virus) for their propagation. Con-
itions of high multiplicity of infection (m.o.i.) favor the
mplification of DI particles. Two basic patterns of trun-
ation result in replicons constituting infectious DI par-
icles (Perrault, 1981) (Fig. 1), although more complex
tructures have been observed (Nichol et al., 1984). In
he first pattern, called “deletion defective replicons,” the
tandard genomic 39 and 59 termini are retained. Like
heir standard homologs, deletion defective replicons
hus contain two different terminal cis sequences for
romoting the synthesis of either antigenomes or ge-
omes. In the pattern called “copyback defective repli-
ons,” the molecule is derived exclusively from the
enomic 59-end and both ends are self-complementary.
ermini of copy-back replicons therefore only contain
ne type of replication promoter, the one originally
resent on standard antigenomes.
Defective-interfering particles are associated with two
mportant phenomena: attenuation and persistence. For
ecades, it has been known that serial undiluted virus
assages can result in virus attenuation in animals, em-
ryonated eggs, or tissue culture cells (Holland et al.,
982; Roux et al., 1991). As mentioned above, these
onditions favor the amplification of DI particles. A more
bvious link between attenuation and DI particles in
issue culture can be shown if DI particles are directly
ixed with homologous standard virus. In a typical in-
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115EBOLA VIRUS DI PARTICLES AND PERSISTENCEerference assay, the presence of DI particles results in
ttenuation, delay, or absence of the cytopathic effect
FIG. 1. Diagramatic representation of the general structure of virus d
ense) RNA is shown in black, and the antigenome (plus sense) is s
tandard virus minus and plus sense RNAs, respectively. The black tria
NAs, respectively, which represent the complement of the promoters
nd are indicated below each type of molecule. Models of deletion and
enomic termini, but have large regions of the standard virus RNA del
remature polymerase termination and reinitiation occured during synt
enerated during replication of the virus antigenome (1 strand template
erminates (position c) and detaches from the antigenome template RN
NA just synthesized (position d9). The nucleotide position of premature
I produced. These molecules can then replicate to produce the predo
enomes with complementary termini (frequently referred to as panhan
nd (open triangle). The hatched region represents the copied area of
tructures. This terminal complentarity results in the 39 termini of both th
inding site (open square). The position of primers used for RT-PCR aCPE) normally associated with the standard virus, and in idecrease in the yield of progeny virus. In some cases,
nfected cells survive and become long-term persistently
RNAs and strategy of RT-PCR amplication. The virus genome (minus
white. The white triangle and box indicate the 39 promoters on the
d box indicate the 59 ends of the standard virus plus and minus sense
otide positions are relative to the standard virus genome 39 terminus
ack DI antigenomes are also depicted. Deletion DI always retain both
eletion DI positions a and b represent the recombination point where
he genomes of copyback DI are more complex and are thought to be
. As the polymerase synthesizes the minus strand copy, it prematurely
reinitiates synthesis close to the 59 end of the minus strand nascent
tion and reinitiation is random and is a unique feature of any particular
tly plus sense DI antigenome depicted. This mechanism generates DI
which lack sequences originating from the standard virus genomic 39
cent RNA, which is capable of forming the complementary panhandle
mic and antigenomic copyback DI RNAs containing the virus replicase
tion of DI breakpoints are indicated below the models.efective
hown in
ngle an
. Nucle
copyb
eted. D
hesis. T
) 39 end
A and
termina
minan
dles),
the nasnfected cell lines. Although it is clear that DI particles
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116 CALAIN, MONROE, AND NICHOLan play an important role in the initiation and mainte-
ance of persistent infections per se, other factors (ts
utants, interferon, cell membrane alterations, or other
ell mutations) can also be involved (Ahmed et al., 1981;
oscona et al., 1993; Segev et al., 1995; Stanners et al.,
977).
Research strategies based on reverse genetics have
ecently been developed for several nonsegemented
egative-stranded RNA viruses. Full-length infectious
lones are now available for rabies virus (Schnell et al.,
994), vesicular stomatitis virus (Lawson et al., 1995;
helan et al., 1995), measles virus (Radecke et al., 1995),
endai virus (Garcin et al., 1995), respiratory syncitial
irus (Collins et al., 1995), and human parainfluenza virus
ype 3 virus (Hoffman and Banerjee, 1997). Such tech-
iques are obviously important for gaining an under-
tanding of virus/host interactions in cell culture and
ltimately in the infected host. As a preliminary approach
o reverse genetics of filoviruses, we have carried out a
eries of experiments that have generated an evolving
opulation of Ebola virus DI particles and a monkey cell
ine persistently infected with Ebola virus. Detailed anal-
sis of these systems also provides insight into Ebola
irus replication and persistence in natural infections.
RESULTS
bola virus high multiplicity passage leads to
roduction of virus DI particles and
ersistently infected cells
An Ebola virus undilute passage series was initiated
y infection of cells at an m.o.i. greater than one of a
irus stock (designated PO) which had been prepared
reviously by low m.o.i. passage (see Materials and
ethods). A series of 10 undiluted Ebola virus passages
designated P1 to P10) were successfully carried out.
rom passage 7 until passage 10, the yield of infectious
irus particles decreased such that it was no longer
ossible to ensure an m.o.i. above 1 with the successive
nocula. In parallel to this drop in infectious virus yields,
he time of appearance of the virus induced CPE also
ecame much delayed. By virus passage P10, the in-
ected cell monolayer remained intact, and on passaging
f the cells, no virus-induced CPE was seen up to 32
ays postinfection (p.i.). Standard virus particles capable
f causing CPE were still present in these P10-infected
ells as the supernatant removed from these cells 3 days
.i. yielded 2.6 3 104 infectious virus particles capable of
ausing cell death as indicated by their ability to form
laques in a traditional virus plaque assay (Table 1).
hese data strongly suggest that the lack of CPE ob-
erved in cells generating virus P10 was due to gener-
tion of virus interfering particles, and not to selection of
oncytopathic standard virus. To examine this further,
assage 10 virus was assayed for the ability to interfere
ith standard virus replication as described under Ma-erials and Methods. Cells challenged with standard
orking stock virus were almost totally protected from
ndergoing CPE when P10 virus was added to the initial
noculum (Table 1). By comparison, control cells infected
ith working stock virus alone underwent strong CPE,
ith most cells being destroyed by 3 days p.i. In addition
o protection from CPE, working stock virus yields were
educed by greater than 90% in the cultures infected in
he presence of P10 virus (Table 1). The development of
irus interference capability correlated with the appear-
nce of virus-defective RNAs detectable by Northern blot
nalysis (see below). Taken together, these data indicate
hat DI particles had been generated during the high
ultiplicity passage series.
eneration of stable Ebola virus persistently infected
ell lines
At day 7 p.i., the VeroE6 cells infected with P9 virus
i.e., those yielding P10 virus) were passaged by splitting
he cells following trypsinization of the monolayer. Sub-
equent passaging of the cells continued at approxi-
ately 2-week intervals. After four passages, the cell
onolayers underwent crisis and exhibited extensive
PE with lysis of approximately 90% of the cells. By
onvention, cells were designated according to their
assage history: “Pix.Cy” where x is the number of cell
assages after the P10 infection and y is the number of
pontaneous crisis events. Cells remaining after the first
risis recovered and could be stably propagated for four
o six additional passages, at which times cell stocks
Pi8.C1 and Pi10.C1) were frozen. From thawed aliquots
f the frozen cells, two lineages could be recovered and
tably maintained for at least 30 passages. One lineage
Pi9.C2 derived from Pi8.C1) underwent an additional
risis early after resumption of the culture but remained
table thereafter. The other lineage was derived from a
ample of Pi10.C1 cells and remained stable upon prop-
gation.
TABLE 1
Virus Interference Assay
Inoculum Virus yielda
Percentage
yieldb CPEc
tandard virus 2.0 3 106 100.0 11111
tandard virus 1 P10 1.3 3 105 6.5 1/2
10 stock alone 2.6 3 104 1.3 2
ock infected 0.0 0.0 2
Note. The working stock was used as a source of standard virus (see
aterials and Methods). Titers of the inocula were 1.2 3 106 and 3 3
05 PFU/ml for working stock and P10 virus, respectively.
a PFU/ml at 3 d.p.i.
b Percentage yield relative to standard working stock virus.
c CPE assayed at 3 d.p.i.Almost all cells in both cell lineages appeared to be
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117EBOLA VIRUS DI PARTICLES AND PERSISTENCEersistently infected and expressed viral antigens as
etermined by immunofluorescence assay using an anti-
bola polyclonal antibody (Fig. 2A). In addition, virus
FIG. 2. Immunoflourescence analysis of Ebola virus persistently inf
eroE6 cells (B) analyzed by immunoflourescence using an Ebola viruersistence could also be demonstrated by immunohis- aochemistry and electron microscopy (data not shown).
ersistent virus shedding was demonstrated by titration
f virus in the cell supernatants. Typical virus yields early
4
ells. Ebola virus persistently infected cells Pi21.C2 (A) or uninfected
fic polyclonal antibody.ected cfter cell monolayer confluence were between 5 3 10
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118 CALAIN, MONROE, AND NICHOLnd 5 3 105 PFU/ml, with no obvious difference between
he two cell lines. While the viruses released from Pi
ells tended to have a small plaque phenotype relative to
he starting P0 virus stock, cell infections initiated with
icked plaques of these Pi viruses were found to display
s extensive CPE as those initiated with P0 virus stocks.
his observation would be consistent with the lack of
PE in the persistently infected cells being related to the
resence of virus DI particles rather than selection of
oncytopathic standard viruses. As expected, these per-
istently infected cell lines were resistant to homologous
irus challenge. For instance, Ebola P0 virus caused
xtensive CPE in Vero E6 cells, but no CPE in Pi5.C1
ells 5 days postchallenge (data not shown). Extensive
PE was seen in both Vero E6 and Pi5.C1 cells 24 h
ostinfection with vesicular stomatitis virus (VSV), dem-
nstrating that we had not merely selected Pi cell lines
esistant to virus CPE in general. Further, the resistance
o superinfection was shown to be Ebola virus specific
s Pi24.C1 cells were still resistant to Ebola P0 virus
PE, but were completely susceptible to Marburg virus
nfection, showing extensive CPE by 8 days post-Mar-
urg virus infection (data not shown).
etection of Ebola virus defective RNAs in undilute
assaged virus and persistently infected cells
The data presented above strongly suggested DI par-
icles had been generated during undilute Ebola virus
FIG. 3. Northern blot analysis of total RNA from cells infected with Eb
heir first (Pi4.C1, Pi25.C1) or second (Pi28.C2) crisis. The left and righ
ethods), respectively. RNA from mock-infected cells are indicated with
f full-length nondefective RNA genomes. Size and position of cold tran
imes of the two membranes were chosen so the intensity of nondefecassage and had allowed initiation and maintenance of (bola virus persistently infected cells. Two main classes
f DI particles have been seen in other nonsegmented
egative strand viruses, namely, deletion and copyback
I (see Introduction and Fig. 1 (Perrault, 1981)). In North-
rn blots, deletion DI RNAs would be expected to hybrid-
ze to riboprobes for the standard genome 39 or 59 ter-
inal sequences, but not to probes for central regions of
he genome such as the VP40 gene. Copyback DI RNAs
ould be expected to hybridize to riboprobes for stan-
ard genome 59 terminal sequences but not 39 terminal
r central genome regions such as the VP40 gene.
To determine whether such deletion or copyback RNA
olecules were present in undilute virus passage mate-
ial or persistently infected cells, total cell RNA from each
irus passage and selected persistently infected cell
assages was analyzed by Northern blot using plus
ense riboprobes to detect standard genome 39 and 59
ermini (rNP and rL, respectively, Fig. 3). Prominent sub-
enomic RNA species were detectable in both the undi-
uted passage and persistent infection RNA samples,
sing the 39 and 59 probes. It is unlikely that these
ubgenomic RNAs represent breakdown products of vi-
us standard genome RNAs as no such subgenomic
NA bands were detected with a VP40 riboprobe, even
fter considerably longer exposure of the northern blot
data not shown). Subgenomic RNAs were quite promi-
ent by the third undilute (P3) virus passage (Fig. 3), and
ould actually be detected as early as the P2 passage
us passages P0, P3, and P10 and from persistently infected cells after
ls show total cell probed with rNP and rL probes (see Materials and
Straight line indicates origin of migration, and arrow indicates position
used as molecular weight markers are indicated on the left. Exposure
nomes would be approximately comparable between the two panels.ola vir
t pane
an m.
scriptsdata not shown). During the undilute virus passage and
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119EBOLA VIRUS DI PARTICLES AND PERSISTENCEersistently infected cell passage series, the amount of
tandard virus RNA detectable cycled up and down, and
he population of subgenomic RNA molecules appeared
o progressively evolve toward lower molecular weight
pecies. Early passages (from Pi1 to Pi3) of the persis-
ently infected cells (data not shown) displayed the same
ubgenomic RNA pattern as seen in the undilute virus
assage 10 material (lane P10, Fig. 3). The differences
bserved in the pattern of subgenomic RNA species
etected using probes rL and rNP suggested that both
eletion (reacting with both rL and rNP) and copy-back
reacting only with rL) variants were present in the RNA
opulation. Immediately following the first cell crisis
Pi4.C1), all defective RNA species appeared to be re-
laced by RNAs of approximately 1 kb in size, detected
y both probes rL and rNP (see lane Pi4.C1, Fig. 3). As
escribed below, reverse transcriptase-polymerase
hain reaction (RT-PCR) analysis showed that this RNA
opulation is actually heterogeneous, comprising at
east two distinct species of both virus deletion and
opy-back defective RNA species.
Northern blot analysis of RNA from the later passages
f Pi cells (lanes Pi25.C1 and Pi28.C2 in probe rL panel,
ig. 3) showed differences in the migration pattern of
ubgenomic RNA molecules, compared to Pi4.C1 sam-
les. However, the most dramatic change is the disap-
earance of species reacting with the rNP probe in
ineage PiC1, and the emergence of new prominent spe-
ies reacting exclusively with probe rL in both lineages.
FIG. 4. RT-PCR analysis of Ebola virus defective RNAs. Total RNA wa
ersistently infected cells Pi 6.C1 (Pi6), and from virion RNA 807346. M
Ba, CBb, and CBc primer combinations (see Fig. 1) are shown.his suggested that copy-back defective genomes pro- tressively outcompeted deletion defective RNA species
uring this persistently infected cell passage series.
nalysis of Ebola virus defective RNA species
y RT-PCR
A series of RT-PCR assays were designed for the
etection of Ebola virus deletion (DEL) and copyback
CB) defective RNAs (illustrated in Fig. 1). The RT primer
argeted the 1 sense (antigenomic) copy of the defective
NAs and primed the cDNA synthesis. Then a pair of
CR primers were used to amplify the cDNA region
hich contained the DEL or CB genome rearrangement.
he strategy of detecting molecules of antigenomic (as
pposed to genomic) polarity was chosen in order to
rime and initiate reverse transcription outside of any
egion of intramolecular terminal complementarity
Calain et al., 1992). Three types of CB reactions (CBa,
Bb, and CBc) were designed in order to increase the
hances of detecting CB molecules generated by differ-
nt virus polymerase premature termination and reinitia-
ion events (Fig. 1).
RT-PCR analysis of total RNA preparations from se-
ected virus and persistently infected cell passages was
arried out using the DEL, CBa, CBb, or CBc primer sets
Fig. 4). RNA from an unrelated preparation of Ebola
irions (Stock 807346) was also included in the analysis.
istinct PCR products could be detected exclusively
rom the samples that had been shown to contain defec-
cted from infected cells at different virus passages (P0, P3, P10), from
d MW2 are molecular weight markers. Products generated using Del,s extra
W1 anive RNA molecules by Northern-blot analysis, and also
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120 CALAIN, MONROE, AND NICHOLrom the 807346 virion RNA preparation (Fig. 4). No
mplification products were generated by equivalent
NA amounts from cells infected by P0 (acute infection)
irus. All the reactions, except CBc yielded PCR prod-
cts. For RNA from infected cells, all detectable PCR
roducts were less than 2.5 kb in size.
The most prominent bands generated by reactions
EL, CBa, and CBb were eluted from the gel and se-
uenced either directly or following TA cloning. Seven
istinct sequences could be unambiguously determined.
ssuming classical structures, the full-length pattern of
he corresponding defective molecules was extrapolated
rom the position of the DI-like genome rearrangement
Fig. 5). Of the seven characterized virus defective RNA
olecules, two had deletion-type genomes and five had
opy-back-type genomes. All were derived from persis-
ently infected Pi6.C1 cells, except 15.3, which is a copy-
ack molecule amplified from virion RNA 807346.
In order to rule out that these molecules merely
epresented PCR artifacts, i.e., recombinant molecules
enerated by reverse transcriptase or Taq polymerase
FIG. 5. Deduced structure of seven Ebola virus DI particles. The str
hown in the antigenomic (predominantly plus sense) form. The antige
ense) RNA is shown in black. The white box indicates the 39 promote
he 59 ends of the standard virus plus and minus sense RNAs, respectiv
ositions of DI breakpoints are numbered relative to the standard viru
atched region represents the copied area of the nascent RNA, which
erminus of the molecule.umping events, the actual presence of the recombi- iation sites in the RNA template populations was
onfirmed in four selected cases (del2.5, del3.3, cb6.2,
nd cb10) using new sets of specific primers. Basi-
ally, the PCR primers 2 and 3 shown in Fig. 1, were
ubstituted with new primers designed to span the
irus RNA template recombination points, such that
he site of the RNA template breakpoint will be in-
luded within the primer, 3–12 nucleotides from the
rimer 39-end. Such RT-PCR reactions were designed
n both directions relative to the breakpoint, i.e., to
etect both antigenomic and genomic defective RNAs.
s expected, specific PCR products were generated
rom Pi6.C1 cell RNA and were absent from mock or
cutely infected cells (Fig. 6). Both antigenomic and
enomic sense defective RNAs could be detected.
CR products representing both sides of the RNA
ecombination points had the expected sizes, confirm-
ng that species del2.5 and del3.3 were classical de-
etion defective RNA genomes. For copy-back species,
nly antigenomic copies could be confirmed despite
rying a variety of RT primer annealing conditions. This
of two deletion types and five copyback types of Ebola virus DI are
plus sense) RNA regions are shown in white and the genome (minus
nt on standard virus plus sense. The black triangle and box indicate
ich represent the complement of the promoters (see Fig. 1). Nucleotide
me 39 terminus and are indicated below each type of molecule. The
pable of forming complementary panhandle structures with the otheructures
nome (
r prese
ely, wh
s geno
is cas likely due to the difficulty in RT priming within the
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es off the genome sense RNA templates.
bola virus defective particles can be passaged and
sed as a source of natural minireplicons
While the data presented in the previous sections
ould strongly suggest that the defective RNAs charac-
erized must be released from each infection and pas-
aged to the next, all of the analysis was carried out
sing infected cell RNA. So to directly demonstrate pas-
age of these infectious defective virus particles, virions
ere purified from the supernatant of Pi14.C1 and
i25.C2 cells and inoculated onto fresh VeroE6 cells (see
aterials and Methods). These cells were then probed
or the presence of DI species del2.5, del3.3, and cb6.2
sing the RT-PCR systems developed for the precise
etection of antigenomic copies of these molecules. The
pecific PCR products were not detectable at 1 h p.i.
ruling out any signal from potential carry over of any
oninfectious free virus nucleocapsid or unencapsidated
irus RNA), but was clearly detected 24 h p.i., demon-
trating that a new infectious cycle of defective particles
FIG. 6. Specific PCR detection of Ebola DI species del2.5, del3.3, cb6
or the detection of the 1 or 2 sense forms of del2.5, del3.3, cb6.2, and
NA cleaved with HaeIII. The sizes of the specific products expected
NA samples analyzed were extracted from mock-infected cells (m), f
ersistently infected cells Pi6.C1.ad been initiated with the virions purified from the Pi pell supernatants (data not shown). In addition, de novo
eneration of del2.5, del3.3, and cb6.2 defective repli-
ons was not observed with cells infected with an inoc-
lum of P0 standard virions. Therefore, it was concluded
hat the two lineages of Pi cells propagated and shed at
east three of the defective particles represented in
ig. 5.
One of the initial goals of this study was to see if it was
ossible to generate Ebola virus DI particles which could
e used as natural minireplicons to assay standard virus
upport functions. Such molecules would represent a
seful tool during the development of a reverse genetics
ystem for Ebola virus. Despite several attempts, we
ere unable to produce Ebola virus DI particles free of
tandard virus particles using various gradient ultracen-
rifugation methods. However, by exploiting the large
enome size difference between standard (19 kb) and DI
irus particles, we were able to remove standard virus
ctivity from DI virus-enriched supernatants by UV irra-
iation. The UV dose was empirically determined to
nactivate most of the endogenous standard virus, while
eaving intact the much smaller defective RNA molecules
cb10. Analysis of the PCR products generated using primers specific
I RNAs. MW represents molecular weight markers composed of FX174
sical DI structures are indicated under the lanes where they appear.
lls infected with Ebola virus P0 or with virus stock 807346, and from.2, and
cb10 D
for clas
rom cereviously characterized. The experiment consisted of
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122 CALAIN, MONROE, AND NICHOLsing a preparation of ancestral (P0) standard virus to
upport replication of DI particles present in UV-irradi-
ted virions purified from persistently infected cells
Pi25.C2) (Fig. 7). Replication of copyback 6.2 DI RNAs
ould be detected 3 days p.i. using a RNase protection
ssay (Fig. 7A), and after 1 day with a specific RT-PCR
not shown). Replication of deletion DI species del 2.5
nd del 3.3 were not detectable by RNase protection 3
ays p.i., but could be clearly demonstrated 24 h p.i.,
sing a specific RT-PCR assay (Fig. 7B). In each panel,
he signal specific for the considered DI species (arrow)
as present in cells infected with Pi25.C2 virions (lane
), but not with mock- (lane 1) or P0-infected cells (lane
). UV-irradiation resulted in the disappearance of the
pecific signal (lane 5), but replication was restored by
escue of the UV-irradiated defective stock with P0 viri-
ns (lane 6). These results indicated that such DI parti-
les could be used as natural minireplicons to assay
bola standard virus support functions.
DISCUSSION
Experiments involving live Ebola or Marburg virus
FIG. 7. Rescue of UV-irradiated virions. Vero E6 cells grown in 6-well
ock, (2) P0 standard stock, (3) Pi 25.C2 purified virions, (4) Pi 25.C2 pu
nd (6) Pi 25.C2 purified virions, UV-irradiated 1 P0 standard stock vi
tandard stock, respectively. Cells were harvested in RNA lysis buffe
rotection) or one-tenth (RT/PCR) of the lysate was processed for furth
ays postinfection. MW, pBR322 digested by HpaII and radio-labeled. K
rotected fragment (285 nt). The strong signal of 106 nt corresponds to p
or deletion species del 2.5 and del 3.3 after 1 h, 1 day, and 2 days p
roducts. Molecular weight (MW) markers included are FX174 DNA clave been limited by the need for a maximum biosafety waboratory (BSL4) containment laboratory, thus hindering
nvestigation of classical phenomena such as virus in-
erference or attenuation. Aberrant forms of Ebola Sudan
irus (Ellis et al., 1979) and other filoviruses (Geisbert et
l., 1995) described earlier, may have been the first
orphological evidence of filovirus DI particles. The cur-
ent study focused on the Zaire subtype of Ebola virus
ue to its recent reemergence in Africa (Georges-Cour-
ot et al., 1997) and high lethality of the human infection
Bwaka et al., 1999). The data presented here show that
bola virus DI particles could be generated and virus
ersistently infected cell lines established using the
lassical approach of undilute virus passage. These DI
articles included both classic deletion and copy-back
orms, which appeared to be produced with comparable
fficiency during initial passages. The population of virus
I particles evolved during the virus and persistently
nfected cell passage series, with shorter defective RNAs
utcompeting longer forms, and a progression from the
etection of both deletion and copy-back defective RNAs
n early material to detection of only copy-back defective
NAs in the later passages. Such features are consistent
were infected with the following inocula in a total volume of 0.5 ml: (1)
irions 1 P0 standard stock, (5) Pi 25.C2 purified virions, UV-irradiated,
lculated m.o.i.s were 0.7 and 0.9 for Pi 25.C2 purified virions and P0
tween 1 h and 3 days postinfection as indicated. One-fifth (RNase
lysis. (A) RNase protection assay for copy-back species cb 6.2 after 3
ested riboprobe (389 nt) diluted 1:100 or 1:1000. Arrow indicates cb 6.2
n of nondefective genomic L sequences. (B) RT-PCR reactions specific
ction. Arrows indicate position and sizes of the specific amplification
with HaeIII.plates
rified v
rus. Ca
r at be
er ana
, undig
rotectio
ostinfeith earlier data on DI particles of rhabdovirus and
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123EBOLA VIRUS DI PARTICLES AND PERSISTENCEaramyxoviruses, which suggest that shorter DI particles
eplicate and interfere more efficiently than longer DI
articles and that possession of the presumed higher
fficiency antigenomic promoter on the 39 termini of both
enome and antigenome copy-back DI RNAs affords
hem a replicative advantage over deletion DI (or stan-
ard viruses), which possess the lower efficiency
enomic promoter on their genome RNAs (Re, 1991;
alain and Roux, 1995). Based on the pattern of compe-
ition of Ebola DI RNAs seen here, it would appear that
imilar differences in efficiency in genomic and antige-
omic promoters exist for the filoviruses and paramyxo-
iruses, which are phylogenetically more closely related
o each other than they are to other virus families (Mor-
unov et al., 1995).
The detailed characterization of the naturally occurring
bola virus minireplicons described here, has implica-
ions for the approaches to the development of reverse
enetics systems for Ebola virus. As these minireplicons
ndergo efficient replication and packaging into infec-
ious particles they must contain the necessary genome
lements for RNA encapsidation and polymerase com-
lex binding and function. Possession of competent pro-
oters at the 39 termini of DI genome and antigenome
NAs is an obvious requirement, but other more subtle
eatures of an efficient replicon may also be contained.
or instance, a relative need for any replicative molecule
o have a genome length of a multiple of six nucleotides
frequently referred to as the “rule of six”), has been
ormally demonstrated for several members of the sub-
amily Paramyxovirinae, including Sendai (Calain and
oux, 1993), human parainfluenza 3 (Durbin et al., 1997),
nd simian virus 5 (Murphy and Parks, 1997), and is also
ikely to apply to measles virus (Sidhu et al., 1995).
owever, replication of minigenomes of respiratory syn-
itial virus, the prototype of the subfamily Pneumovirinae,
ere not constrained by a rule of six or any other com-
on integer divisor (Samal and Collins, 1996). Virus
RNA editing is carried out by viruses of the subfamily
aramyxovirinae, but not those of the subfamily Pneumo-
irinae. As the presence of a cotranscriptional editing
ite in the P gene results in instability at this site during
enome replication (Hausmann et al., 1996), it seems
ossible that the rule of six in Paramyxovirinae subfamily
iruses may be evolutinarily linked to their need to elim-
nate genomes with length variations due to RNA editing.
he possibility of a length rule applying in Ebola virus
eplication was considered due to the phylogenetic re-
atedness of Ebola virus to the paramyxoviruses and the
NA editing seen during Ebola virus glycoprotein mRNA
ynthesis (Sanchez et al., 1996; Volchkov et al., 1995).
he recently revised genome length (18960 nucleotides;
owner and Sanchez, unpublished; Genbank Accession
os. L11365 and X67110; Sanchez et al., 1993; Volchkov
t al., 1999) of the Ebola Zaire virus, Mayinga strain, is
ivisable by six. However, only one of the seven Ebola tirus naturally occuring minireplicons characterized here
ere found to be divisable by six. Further analysis re-
ealed no other common integer divisor among these
bola minireplicons (Fig. 5). Although Marburg virus
oes not carry out RNA editing, the genome of the Mu-
oke strain (19104 nucleotides; Feldmann et al., 1992;
evised in GenBank Z12132) is divisable by six, but not
hat of the Popp strain (19112 nucleotides; Bukreyev et al.,
995). Based on these observations it appears that a
ength rule will not be applicable to the filoviruses.
The apparent lack of an integer length rule is one more
eature shared by the viruses of the Filoviridae family,
espiratory syncitial virus (RSV), and other members of
he Pneumovirinae subfamily. RSV is also phylogeneti-
ally closer to the filoviruses than are other viruses
Morzunov et al., 1995), and gene overlaps exist in RSV
nd Ebola and Marburg viruses (Collins, 1991; Sanchez
t al., 1993). In addition, their attachment glycoprotein is
-glycosylated (Feldmann et al., 1994), and their glyco-
rotein genes encode both membrane-anchored and
oluble forms of the glycoprotein, albeit by different
echanisms (Sanchez et al., 1996; Roberts et al., 1994).
iven the similarities, results of RSV studies may provide
nsights applicable to filovirus biology and approaches to
ntiviral and prototype vaccine development.
The extent of the Ebola virus RNA terminal sequences
ecessary for efficient Ebola virus replication and pack-
ging is currently unclear due to the lack of detailed
apping experiments and the unusually long terminal
oncoding regions. The Ebola Zaire virus genome 39
erminus contains a 469-nt region upstream of the N
rotein open reading frame (Sanchez et al., 1989), with
he terminal 53 nt up to the N mRNA initiation site making
p the leader region (Sanchez et al., 1993). The position
f the L mRNA transcription termination-polyadenylation
ite has recently been mapped to genome region
AAUAUUUUUU at genome nucleotide positions 18273
o 18283 (position as corrected by Towner and Sanchez,
npublished), resulting in a 677-nt trailer region at the
enome 59 terminus (Volchkov et al., 1999). It is reason-
ble to assume that the shortest Ebola virus minirepli-
ons described here (del 3.3 and cb6.2; see Fig. 4) carry
ll the cis-acting sequences necessary for efficient virus
eplication and packaging since these minireplicons
ere shown to propogate from cell to cell through virus
articles. From these structures, we can infer that 155 nt
f the genomic 39 terminus and 176 nt of the antigenomic
erminus are sufficient to allow binding of the viral poly-
erase complex and subsequent initiation of RNA rep-
ication and encapsidation. Recently, a Marburg virus
rtificial minigenome has been successfully replicated
hich contained 106 and 439 nt of the standard virus
enome 39 and 5 termini, respectively, flanking a CAT
eporter gene (Muhlberger et al., 1998). More recently,
his same group has described the successful replica-
ion of an Ebola minireplicon containing 472-nt leader
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124 CALAIN, MONROE, AND NICHOLnd 731-nt trailer regions flanking the CAT reporter
Muhlberger et al., 1999). Together these data will aid the
esign and manipulation of Ebola virus artificial mini-
enomes for use in development of Ebola virus reverse
enetics systems.
The natural reservoir of Ebola virus remains an
nigma. Some filovirus infections of humans have been
nitiated by contact with sick or dead monkeys or apes,
r their tissues (Georges-Courbot et al., 1997; Kissling et
l., 1970; LeGuenno et al., 1995), but most cases have
ccured through close contact with disease patients or
heir fluids (World Health Organization, 1978a,b; Dowell
t al., 1999). Insect or plant hosts are not considered
ikely based on the lack of virus growth in insect cells
nd the absence of any sequence identity with know
lant RNA viruses (Van der Groen et al., 1978). The most
ignificant clue is likely the high sequence identity seen
etween an immunosuppresive domain present in enve-
ope glycoproteins of retroviruses of higher vertebrates
nd a similar domain in filovirus GP proteins (Volchkov et
l., 1992; Sanchez et al., 1993; Lu et al., 1995; Gallaher,
996). Such data have suggested mammals or birds as
otential hosts although Ebola virus is generally consid-
red to be an acute infection resulting in extensive cy-
opathology in many mammalian cells. However, the
ase with which we were able to establish an Ebola virus
ersistently infected mammalian cell line and resulting
ontinuous shedding of infectious virus, along with re-
ent data on experimental infection of bats (Swanepoel
t al., 1996), suggest that mammal or bird potential hosts
f Ebola virus warrant further investigation.
Filovirus persistence following naturally acquired in-
ection of humans has been reported previously. Mar-
urg virus was isolated from the seminal fluid and ante-
ior chamber of the eye of convalescent hemorrhagic
ever patients up to 80 days post-onset of disease (Mar-
ini, 1969; Smith et al., 1982). Ebola Sudan virus has been
ecovered from the seminal fluid of a convalescent pa-
ient 61 days post-onset of disease (Emond et al., 1977).
ore recently, Ebola Zaire virus RNA could be detected
or up to 33 days after disease onset in vaginal, rectal,
nd conjunctival swabs of a patient, and up to 101 days
fter disease onset in the seminal fluid of 4 patients
Rodriguez et al., 1999). Infectious virus was detected in
he seminal fluid of one of these patients 82 days after
isease onset. Our demonstration that a cell line of
rimate origin can be persistently infected with a filovirus
dds credence that such instances of prolonged shed-
ing in humans are genuine cases of persistent infection
n vivo.
Ebola live-attenuated vaccines could be of some
alue, particularly an Ebola Reston vaccine for use in
nimals in primate-holding facilities (Rollin et al., 1999).
ur study suggests that the production of an Ebola virus
ttenuated strain might be possible using the viruses
enerated by undilute passage or from persistently in- oected cells. In at least two examples, DI particles were
etected in live-attenuated vaccines and were sug-
ested to play a role in attenuation (Calain and Roux,
988; McLaren and Holland, 1974; Roux et al., 1991).
long these lines, it will be of interest to determine the
irulence in experimental animals of the Ebola viruses
eleased from the virus undilute passage or persistently
nfected cell series. In addition, reverse genetics tech-
iques offer the prospect of producing pure, nonvirulent,
mmunogenic Ebola viruses by engineering of a cloned
nfectious virus genome.
MATERIALS AND METHODS
ells and virus passages
All experiments involving infectious Ebola viruses
ere carried out in a biosafety level 4 (BSL4) laboratory.
ero E6 (ATCC CRL-1586) cells were used for the prop-
gation of Ebola virus and for the generation of virus DI
articles. A Vero ATCC CCl-81 cell line was used for
escue of purified defective virus stocks because of their
olerance to repeated transfections and vaccinia infec-
ions which were anticipated in future reverse genetic
tudies.
Prior to initiation of virus undilute passage experi-
ents, several stocks of Ebola-Zaire, Mayinga strain
irus (originally isolated from a 1976 patient) were as-
essed for their ability to grow rapidly and produce high
ytopathology. A plaque purified virus stock (806567) had
een prepared earlier from the patient sample by 3
assages in Vero cells followed by 3 plaque purifications
nd selection of large plaques (Sanchez et al., 1996).
his virus was found to grow more quickly (causing
xtensive CPE by 3 days postinfection) than earlier non-
laque purified virus stocks or other nonmutant plaque
urified viruses. Due to these growth capabilities, this
irus stock was chosen to initiate the serial undiluted
assage of Ebola virus in Vero E6 cells. Previous nucle-
tide sequence analysis of virion RNA from this stock
howed that an additional U base has been inserted in a
tring of 7 Us representing the glycoprotein gene editing
ite, resulting in the synthesis of a full-length glycopro-
ein from primary, unedited transcripts (Sanchez et al.,
996). A virus working stock was made from the clarified
upernatant of cells infected with stock 806567 at an
.o.i. of approximately 1. It is worth noting that the 8-U
enotype of these viruses did not vary during the virus
ndilute passage series or persistent infection passages
escribed here (data not shown).
Preliminary experiments also indicated that during tis-
ue culture cell infection, release of Ebola virus infec-
ious particles into cell culture medium was incomplete
ith significant amounts of infectious virus remaining
ell-associated. In addition, earlier Ebola virus infectivity
nd electron microscopy studies had shown that heter-
genous elongated virus particles could be resolved into
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125EBOLA VIRUS DI PARTICLES AND PERSISTENCEmaller more homogeneous sized particles with in-
reased infectivity by sonication (Russ Regnery, personal
ommunication). For these reasons, undilute virus pas-
age experiments were carried out using sonicates of
arvested infected cells suspended in their supernatant
luid, in order to maximize virus yields.
Serial passages were initiated by infecting cells with
orking stock virus at an m.o.i. of 0.2. Extensive CPE was
vident after 5 days and cells were scraped in approxi-
ately 10 ml of their supernatant per 75-cm2 flask. The
ell suspension was sonicated for 60” on a refrigerated
ater bath (Tekmar7 Sonic Disruptor, position 8, 90%
uty cycle). The resulting virion preparation was called
P0” and used undiluted to initiate the next infection at a
igh m.o.i. Subsequent serial passages (from “P1” to
P10”) were carried in the same way, using the undiluted
onicate of the previous infection as inoculum. At each
assage, one T75 flask was harvested for analysis of
otal RNA, and another two T75 flasks for preparation of
he next inoculum. In some experiments (Fig. 4), addi-
ional controls used RNA from Ebola virus stock 806346.
his stock was generated independently from stock
06567 by serial passages of the Mayinga strain at low
.o.i. in Vero cells without plaque-purification. Plaque
itrations were carried out according to standard tech-
iques (Ksiazek et al., 1999).
assage, immunofluorescence, and storage of Ebola
ersistently infected cells
Ebola virus persistently infected cells were split 1:4 at
ntervals between 7 and 14 days, using trypsin-EDTA
olution (GIBCO BRL). Rapid assessment of continuing
nfection was carried out by immunofluorescence assay
ssentially as described earlier (Ksiazek et al., 1999).
tocks of persistently infected cells were made in 10%
MSO-containing medium and stored in liquid nitrogen.
nterference and superinfection assays
For assay of interference, T25 flasks of confluent Vero
6 cells were infected with a mixture of virus stock (m.o.i.
f 0.3) and 1 ml of test preparation. Controls included
dentical concentrations of stock alone, test preparation
lone, and medium alone. Cells were checked daily for
ppearance and intensity of CPE. Virions released were
easured 3 days p.i. by plaque assay of the cell super-
atants. Superinfection assays were carried out using
25s of newly confluent Ebola persistently infected cells,
s well as normal E6 cells, either mock infected or
uperinfected with stock P0 virus at an m.o.i. of 0.1 for
h. Fresh medium was then added and sampled 2 and
days p.i. by plaque assay for virus release.
bola virus riboprobes
Plasmid pEBO 7 was constructed by inserting a PCR
ragment spanning nucleotides 17343 to 18960 of the abola Zaire virus Mayinga strain, into pCR II (Invitrogen)
loning vector. A positive riboprobe (rL) extending to the
9-genomic terminus was obtained after linearization
ith Mlu1 and transcription with T7 RNA polymerase.
lasmid pGEM-EV3 has been described previously
Sanchez et al., 1993). After digestion with NcoI, a posi-
ive riboprobe (rVP40) including 1014 nucleotides of the
P40 gene, was produced by transcription with SP6 RNA
olymerase. Plasmid pEBO 47 (kindly provided by A.
anchez) was digested with SalI, followed by transcrip-
ion with SP6 polymerase to produce a positive ribo-
robe (rNP) spanning the first 469 nucleotides of the
9-genomic terminus. For the detection of defective mol-
cules cb 6.2 (see Results) by RNase protection, plasmid
EBO 43 was constructed by inserting into pSP73, an
T-PCR product spanning the breakpoint region of the
opy-back molecule (for orientation, see Fig. 1). After
inearization with EcoRV and transcription with T7 RNA
olymerase, the resulting riboprobe contained the entire
nverted complementary repeat (negative sense) fol-
owed by 106 nucleotides of nonrepeat sequences (pos-
tive sense). Additional RNA flanking sequences were
ranscribed from polylinker regions.
For Northern-blot analysis, riboprobes were made in
0-ml reactions containing 1 mg of linearized plasmid, 40
nits of RNase inhibitor (Boehringer), 1 mM each of cold
TP, GTP, and ATP, 0.05 mM of cold UTP, 50 mCi of
a-32P]UTP (Amersham), and 20 units of the appropriate
NA polymerase (SP6 or T7 polymerase, Boehringer) in
uffer according to the manufacturer’s instructions. For
Nase protection experiments (6–12 samples analyzed),
he above reaction was scaled up fivefold and the ribo-
robe was purified on a G-50 Sephadex column.
orthern blot
Total cell RNA was extracted and purified using a
ommercially available kit (RNaid, Bio101 Inc.). One mi-
rogram of each RNA sample was electrophoresed on a
.2% agarose formaldehyde denaturing gel, transferred to
itrocellulose according to standard procedure (Sam-
rook et al., 1989, pp. 7.43–7.48). Cold transcripts of
pposite polarity to the rL riboprobe were run in parallel
s size markers. The appropriate riboprobe was then
dded and hybridization was carried out at 48°C for a
inimum of 8 h. Blots were analyzed by exposing nitro-
ellulose filter to X-ray film.
ibonuclease protection
Total cell lysates were directly probed for defective
olecules using the Lysate Ribonuclease kit as de-
cribed by the manufacturer (United States Biochemical).
he overnight hybridization temperature was 45°C. As a
ontrol, the riboprobe was incubated in cell lysate buffer,
nd treated as the test samples, except the ribonuclease
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126 CALAIN, MONROE, AND NICHOLixture was omitted. Protected fragments were analyzed
n a 4% acrylamide-urea gel.
T-PCR and nucleotide sequence analysis
RNA was extracted from cells or purified virions as
escribed for Northern blot analysis. Reverse transcrip-
ion of 1 mg RNA was carried out with Superscript II
GibcoBRL) according to manufacturer’s instructions. The
esulting c-DNA preparation was diluted fivefold with
ater and 2 ml was used for PCR amplification using
xpand High Fidelity PCR System (Boehringer) as indi-
ated in the manufacturer’s protocol. The program used
or amplification of defective species in Fig. 1 was: 94°C
or 2 min, followed by 15 cycles of [94°C for 15 s/45°C for
0 s/72°C for 3 min] followed by 20 cycles of [94°C for 15
/45°C for 30 s/72°C for 3 min with 20 s additional
longation in each cycle] followed by 3 min at 72°C. PCR
roducts were analyzed on 3% agarose gels and purified
sing the Sephaglas BandPrep kit (Pharmacia). Purified
CR products were directly sequenced, or cloned
pCR2.1 cloning kit, Invitrogen) when direct sequencing
as problematic. Inserts of six independent clones were
onfirmed to be identical by restriction analysis before
equences were determined using original PCR primers,
s well as vector primers, by the dyedeoxy-termination
ethod (ABI Prism Dye Terminator FS, Perkin–Elmer).
urification and UV-irradiation of virions
Culture supernatants were clarified by low speed cen-
rifugation (Beckman GPR centrifuge, 2500 rpm for 5
in), then layered on a 10-ml cushion of 20% sucrose
nd centrifuged for 20 min at 60,000g in a SW28 rotor.
irion pellets were resuspended in DMEM and stored in
iquid nitrogen. When required, standard virus particles
ere eliminated from DI virion preparations by UV irra-
iation. Samples were put in 6-well plates (1 ml/well) and
rradiated in an ultraviolet crosslinker (Model UCV-508,
ltra-lum, Inc.). Doses of 5 mJ/cm2 were empirically de-
ermined to cause a steady decrease of 100-fold in the
irus titer of Ebola Zaire virus. In rescue experiments,
irion preparations from persistently infected cells were
rradiated with 20 mJ/cm2 (no standard virus detectable
y plaque assay) before innoculating cultures for 1 h as
ndicated in Fig. 7. Cell monolayers were washed twice
ith culture medium before maintenance media was
dded.
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